XML 22 R12.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stockholders' Equity | 6 Months Ended
--- | ---
Jun. 30, 2024
Stockholders' Equity |
Stockholders' Equity | (7) Stockholders’ Equity ​ In November 2023, the Company filed an automatic shelf registration statement with the SEC to register for sale any combination of the types of securities described in the shelf registration statement, including shares of its common stock. Also in November 2023, the Company issued 8,538,750 shares of its common stock in an underwritten public offering resulting in net proceeds to the Company of $216.2 million, after deducting underwriting fees and offering expenses. ​ On February 26, 2024, the Company entered into a controlled equity offering sales agreement (“ATM Agreement”) with Cantor Fitzgerald & Co. (“Cantor”) to allow the Company to issue and sell shares of its common stock from time to time through Cantor, acting as agent. Also on February 26, 2024, the Company terminated its pre-existing controlled equity offering sale agreement dated May 19, 2016 with Cantor. At June 30, 2024, the Company had registered $300.0 million of its common stock to be sold pursuant to the Company’s ATM Agreement, all of which remained unsold as of that date. ​ In March 2024, the Company issued 9,798,000 shares of its common stock in an underwritten public offering resulting in net proceeds to the Company of $432.3 million, after deducting underwriting fees and offering expenses. ​ The changes in Stockholders’ Equity during the three and six months ended June 30, 2024 and 2023 are summarized below: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | ​ | ​ |  | Accumulated |  | ​ | ​ |  | ​ | ​
​ | ​ | Common | ​ | Common | ​ | Additional | ​ | Other | ​ | ​ | ​ | ​ | Total
​ | ​ | Stock | ​ | Stock Par | ​ | Paid-In | ​ | Comprehensive | ​ | Accumulated | ​ | Stockholders’
​ |  | Shares |  | Value |  | Capital |  | Income |  | Deficit |  | Equity
​ | ​ | (In thousands, except share amounts)
Consolidated balance at December 31, 2023 |  | 55,883,377 |  | $ | 56 |  | $ | 1,823,168 |  | $ | 3,308 |  | $ | (1,397,361) |  | $ | 429,171
Shares issued under stock option and employee stock purchase plans |  | 229,171 |  |  | — |  |  | 3,814 | ​ | ​ | — |  |  | — |  |  | 3,814
Shares issued in underwritten offering, net |  | 9,798,000 |  |  | 10 |  |  | 432,288 |  |  | — |  |  | — |  |  | 432,298
Stock-based compensation |  | — |  |  | — |  |  | 7,202 |  |  | — |  |  | — |  |  | 7,202
Unrealized loss on marketable securities |  | — |  |  | — |  |  | — |  |  | (1,064) |  |  | — |  |  | (1,064)
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (32,808) | ​ |  | (32,808)
Consolidated balance at March 31, 2024 |  | 65,910,548 |  | $ | 66 |  | $ | 2,266,472 |  | $ | 2,244 | ​ | $ | (1,430,169) |  | $ | 838,613
Shares issued under stock option and employee stock purchase plans | ​ | 370,119 | ​ | ​ | — | ​ | ​ | 3,712 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 3,712
Stock-based compensation | ​ | — | ​ | ​ | — | ​ | ​ | 7,640 | ​ | ​ | — | ​ | ​ | — | ​ | ​ | 7,640
Unrealized loss on marketable securities | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (464) | ​ | ​ | — | ​ | ​ | (464)
Net loss | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (35,842) | ​ | ​ | (35,842)
Consolidated balance at June 30, 2024 | ​ | 66,280,667 | ​ | $ | 66 | ​ | $ | 2,277,824 | ​ | $ | 1,780 | ​ | $ | (1,466,011) | ​ | $ | 813,659
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | ​ | ​ |  | Accumulated |  | ​ | ​ |  | ​ | ​
​ | ​ | Common | ​ | Common | ​ | Additional | ​ | Other | ​ | ​ | ​ | ​ | Total
​ | ​ | Stock | ​ | Stock Par | ​ | Paid-In | ​ | Comprehensive | ​ | Accumulated | ​ | Stockholders’
​ | ​ | Shares | ​ | Value | ​ | Capital | ​ | Income | ​ | Deficit | ​ | Equity
​ | ​ | (In thousands, except share amounts)
Consolidated balance at December 31, 2022 |  | 47,200,695 | ​ | $ | 47 | ​ | $ | 1,580,829 | ​ | $ | 1,260 | ​ | $ | (1,255,932) | ​ | $ | 326,204
Shares issued under stock option and employee stock purchase plans |  | 43,986 | ​ |  | — | ​ |  | 694 | ​ |  | — | ​ |  | — | ​ |  | 694
Stock-based compensation |  | — | ​ |  | — | ​ |  | 4,340 | ​ |  | — | ​ |  | — | ​ |  | 4,340
Unrealized gain on marketable securities |  | — | ​ |  | — | ​ |  | — | ​ |  | 863 | ​ |  | — | ​ |  | 863
Net loss |  | — | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | (29,361) | ​ |  | (29,361)
Consolidated balance at March 31, 2023 |  | 47,244,681 | ​ | $ | 47 | ​ | $ | 1,585,863 | ​ | $ | 2,123 | ​ | $ | (1,285,293) | ​ | $ | 302,740
Shares issued under stock option and employee stock purchase plans |  | 9,132 | ​ |  | — | ​ |  | 133 | ​ |  | — | ​ |  | — | ​ |  | 133
Stock-based compensation |  | — | ​ |  | — | ​ |  | 5,217 | ​ |  | — | ​ |  | — | ​ |  | 5,217
Unrealized loss on marketable securities |  | — | ​ |  | — | ​ |  | — | ​ |  | (51) | ​ |  | — | ​ |  | (51)
Net loss |  | — | ​ |  | — | ​ |  | — | ​ |  | — | ​ |  | (30,502) | ​ |  | (30,502)
Consolidated balance at June 30, 2023 |  | 47,253,813 | ​ | $ | 47 | ​ | $ | 1,591,213 | ​ | $ | 2,072 | ​ | $ | (1,315,795) | ​ | $ | 277,537
​

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration